Prostate cancer is a significant global health concern, the prognosis for its cases in the year 2050 is projected and expected to rise by 25%, despite ongoing prevention efforts.
According to the World Health Organization (WHO), the global cancer burden is growing, with an estimated 35 million new cancer cases projected to occur in 2050, a 77% increase from the estimated 20 million cases in 2022.
This projection is based on a study that compared the number of new cancer cases in 2021 to a hypothetical scenario where 100% of major risk factors for cancer were instantaneously eliminated in 2022. The study, conducted in Denmark, analyzed the impact of prevention strategies on the incidence of various cancers, including prostate, breast, colorectal, and lung cancer, under different prevalence scenarios of tobacco smoking, overweight and obesity, and alcohol consumption.
The study found that with 100% prevention of smoking, overweight and obesity, and alcohol consumption beginning in 2022, the number of new breast and colorectal cancer cases would remain unchanged in 2050. However, an increase of 25% in new prostate cancer cases was estimated, as no preventive factors were identified for prostate cancer. This suggests that the increase in prostate cancer cases is non-preventable and is influenced by factors such as gender, age, ethnicity, family history, and genetic variation, which are nonmodifiable.
The study also highlighted the significant potential for the prevention of lung cancer, with almost 70% of new cases being preventable by 2050 when tobacco smoking is eliminated. This is due to smoking being the leading cause of lung cancer and responsible for at least three out of four incident cases in Denmark. The study also noted that smoking might influence the risk of developing prostate cancer, but the evidence is not clear. Neither alcohol nor overweight are proven to affect the risk of prostate cancer, and the most established risk factors for prostate cancer are nonmodifiable.
The study’s findings underscore the importance of focusing on effective prevention strategies, such as reducing tobacco smoking, which has considerable potential for prevention. However, it also emphasizes the need to acknowledge the unavoidable increase in future incident cancer cases, particularly for prostate cancer, and to incorporate these findings into future health strategies.
ALSO READ: What happens to your skin when you quit smoking?
Symptoms of Prostate Cancer
Prostate cancer is a common type of cancer that affects men, and it often does not cause any symptoms in its early stages. However, as the cancer progresses, it can cause several symptoms that can affect a man’s urinary and sexual function, as well as his overall health.
One of the most common symptoms of prostate cancer is difficulty urinating. Men with prostate cancer may experience a weak or interrupted flow of urine, or they may have trouble starting or stopping urination. They may also need to urinate more frequently, especially at night. This can be caused by the prostate gland pressing on the urethra, the tube that carries urine out of the body.
Another common symptom of prostate cancer is blood in the urine or semen. This can be a sign that the cancer has spread beyond the prostate gland and is affecting other parts of the body.
Prostate cancer can also cause pelvic pain, which can be a sign that the cancer has spread to the bones or other organs. Men with prostate cancer may also experience painful ejaculation.
In addition to these symptoms, men with prostate cancer may experience other symptoms, such as unexplained weight loss, fatigue, or swelling in the legs or feet. These symptoms can be a sign that the cancer has spread to other parts of the body and is affecting the man’s overall health.
It is important to note that these symptoms can also be caused by other conditions, such as benign prostatic hyperplasia (BPH) or prostatitis. However, if a man experiences any of these symptoms, he should speak with his doctor right away to determine the cause and to receive appropriate treatment.
FAQs
How common is prostate cancer?
Prostate cancer is the most common non-skin cancer in men in the U.S., and the 4th most common tumor diagnosed worldwide. In the United States, 1 in 8 men will be diagnosed with prostate cancer in his lifetime. For Black men, 1 in 6 will develop prostate cancer and are more than twice as likely to die from the disease. In 2024, more than 299,000 U.S. men will be diagnosed with prostate cancer, and more than 35,000 will die from the disease.
Are some men more likely to be diagnosed with prostate cancer?
The chance of being diagnosed with prostate cancer increases rapidly after age 50. About 6 in 10 of all prostate cancers are diagnosed in men over the age of 65. For Black men, 1 in 6 will develop prostate cancer and are more than twice as likely to die from the disease. Prostate cancer is among the most heritable of the major human cancers; It is estimated that more than half (57%) of prostate cancer risk is due to genetic factors.
Is prostate cancer curable?
Prostate cancer is one of the more common forms of cancer, affecting more than 3 million men each year. However, it is a complex condition, and you might find that you have quite a few questions after receiving a prostate cancer diagnosis. It’s possible to learn quite a bit about prostate cancer on your own, although you’ll be able to get the most accurate and individualized information by working with an experienced oncologist.
How do I manage the side effects of prostate cancer treatment?
Managing the side effects of prostate cancer treatment involves understanding the potential side effects of the specific treatment being used (e.g., radiation therapy, surgery, chemotherapy) and discussing these with your healthcare provider. This can help in planning for and managing these side effects effectively.
Can testosterone replacement therapy increase the risk of prostate cancer?
Testosterone replacement therapy can increase the risk of prostate cancer, especially in men with a family history of the disease. It’s important to discuss this risk with your healthcare provider before starting testosterone replacement therapy.
